14.900
+0,00%
2026-10-19
Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -22.7% | -40.6% | 0 / 3 | +20.0% | -11.09 pp | -1.31 pp | +8.6% | 0.18 | 4.53 | 810 | +20,0% | 19,2 | −22,7% | 4.53 | 5.01 | −9,6% |
| Pts | 0 | 0 | 0 | 8 | 0 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 14.900 (close price on 2026-10-19)EPS (TTM): 3.291
Financial charts
1.Revenue & growth
VND bn810Q2/26
1.Revenue & growth
VND bn810Q2/26
2.Profit & growth
VND bn19,2Q2/26
3.Profit mix (Penman)
VND bn41,9Q2/26
4.Margins & cost structure
%17.1%Q2/26
5.Returns & cash cycle
% · days7.9%Q2/26
6.Earnings quality & cash
VND bn-18,5Q2/26
7.Asset structure
VND bn1.121Q2/26
8.Funding & debt health
VND bn · times1.121Q2/26
9.Revenue backlog
VND bn1,22Q2/26
10.Valuation
times · %4,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.918Q2/26
Adjusted EPS growth, latest quarter
-22.7%
Average adjusted EPS growth, 3 quarters
-40.6%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26